nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—Panic disorder—Hydrochlorothiazide—nephrolithiasis	0.12	0.153	CcSEcCtD
Alprazolam—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0315	0.0402	CcSEcCtD
Alprazolam—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0315	CcSEcCtD
Alprazolam—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0247	0.0315	CcSEcCtD
Alprazolam—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0225	CcSEcCtD
Alprazolam—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0225	CcSEcCtD
Alprazolam—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0197	CcSEcCtD
Alprazolam—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0141	0.018	CcSEcCtD
Alprazolam—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0148	CcSEcCtD
Alprazolam—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.011	0.0141	CcSEcCtD
Alprazolam—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0138	CcSEcCtD
Alprazolam—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0137	CcSEcCtD
Alprazolam—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0137	CcSEcCtD
Alprazolam—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0136	CcSEcCtD
Alprazolam—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0135	CcSEcCtD
Alprazolam—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0128	CcSEcCtD
Alprazolam—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00998	0.0127	CcSEcCtD
Alprazolam—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0099	0.0126	CcSEcCtD
Alprazolam—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0122	CcSEcCtD
Alprazolam—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00946	0.0121	CcSEcCtD
Alprazolam—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00929	0.0119	CcSEcCtD
Alprazolam—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00909	0.0116	CcSEcCtD
Alprazolam—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00906	0.0116	CcSEcCtD
Alprazolam—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0113	CcSEcCtD
Alprazolam—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00869	0.0111	CcSEcCtD
Alprazolam—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00869	0.0111	CcSEcCtD
Alprazolam—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00813	0.0104	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00808	0.0103	CcSEcCtD
Alprazolam—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00803	0.0102	CcSEcCtD
Alprazolam—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0101	CcSEcCtD
Alprazolam—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0101	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00769	0.00981	CcSEcCtD
Alprazolam—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00756	0.00964	CcSEcCtD
Alprazolam—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00743	0.00948	CcSEcCtD
Alprazolam—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00731	0.00933	CcSEcCtD
Alprazolam—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00888	CcSEcCtD
Alprazolam—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00692	0.00884	CcSEcCtD
Alprazolam—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00875	CcSEcCtD
Alprazolam—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00658	0.0084	CcSEcCtD
Alprazolam—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00828	CcSEcCtD
Alprazolam—GABRB2—Ion channel transport—CLCN5—nephrolithiasis	0.00633	0.0293	CbGpPWpGaD
Alprazolam—GABRB2—Ion channel transport—CLCN4—nephrolithiasis	0.00633	0.0293	CbGpPWpGaD
Alprazolam—GABRA5—Ion channel transport—CLCN4—nephrolithiasis	0.00615	0.0284	CbGpPWpGaD
Alprazolam—GABRA5—Ion channel transport—CLCN5—nephrolithiasis	0.00615	0.0284	CbGpPWpGaD
Alprazolam—GABRA3—Ion channel transport—CLCN5—nephrolithiasis	0.00604	0.0279	CbGpPWpGaD
Alprazolam—GABRA3—Ion channel transport—CLCN4—nephrolithiasis	0.00604	0.0279	CbGpPWpGaD
Alprazolam—Tension—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00759	CcSEcCtD
Alprazolam—GABRA2—Ion channel transport—CLCN5—nephrolithiasis	0.00594	0.0275	CbGpPWpGaD
Alprazolam—GABRA2—Ion channel transport—CLCN4—nephrolithiasis	0.00594	0.0275	CbGpPWpGaD
Alprazolam—GABRB3—Ion channel transport—CLCN4—nephrolithiasis	0.0059	0.0273	CbGpPWpGaD
Alprazolam—GABRB3—Ion channel transport—CLCN5—nephrolithiasis	0.0059	0.0273	CbGpPWpGaD
Alprazolam—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00751	CcSEcCtD
Alprazolam—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00586	0.00748	CcSEcCtD
Alprazolam—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00743	CcSEcCtD
Alprazolam—GABRG2—Ion channel transport—CLCN5—nephrolithiasis	0.00579	0.0268	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—CLCN4—nephrolithiasis	0.00579	0.0268	CbGpPWpGaD
Alprazolam—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00571	0.00728	CcSEcCtD
Alprazolam—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00724	CcSEcCtD
Alprazolam—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00717	CcSEcCtD
Alprazolam—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00557	0.0071	CcSEcCtD
Alprazolam—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00706	CcSEcCtD
Alprazolam—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00697	CcSEcCtD
Alprazolam—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00694	CcSEcCtD
Alprazolam—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00693	CcSEcCtD
Alprazolam—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00535	0.00683	CcSEcCtD
Alprazolam—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00679	CcSEcCtD
Alprazolam—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00658	CcSEcCtD
Alprazolam—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00658	CcSEcCtD
Alprazolam—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00658	CcSEcCtD
Alprazolam—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00656	CcSEcCtD
Alprazolam—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0051	0.0065	CcSEcCtD
Alprazolam—GABRA1—Ion channel transport—CLCN5—nephrolithiasis	0.00506	0.0234	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—CLCN4—nephrolithiasis	0.00506	0.0234	CbGpPWpGaD
Alprazolam—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00644	CcSEcCtD
Alprazolam—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00499	0.00636	CcSEcCtD
Alprazolam—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00631	CcSEcCtD
Alprazolam—Shock—Hydrochlorothiazide—nephrolithiasis	0.00486	0.00621	CcSEcCtD
Alprazolam—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00616	CcSEcCtD
Alprazolam—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0061	CcSEcCtD
Alprazolam—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00601	CcSEcCtD
Alprazolam—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00589	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00575	CcSEcCtD
Alprazolam—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00571	CcSEcCtD
Alprazolam—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00566	CcSEcCtD
Alprazolam—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00562	CcSEcCtD
Alprazolam—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00561	CcSEcCtD
Alprazolam—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00555	CcSEcCtD
Alprazolam—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00548	CcSEcCtD
Alprazolam—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00544	CcSEcCtD
Alprazolam—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00539	CcSEcCtD
Alprazolam—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00407	0.0052	CcSEcCtD
Alprazolam—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00516	CcSEcCtD
Alprazolam—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00501	CcSEcCtD
Alprazolam—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00499	CcSEcCtD
Alprazolam—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00499	CcSEcCtD
Alprazolam—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00465	CcSEcCtD
Alprazolam—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00453	CcSEcCtD
Alprazolam—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00446	CcSEcCtD
Alprazolam—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00432	CcSEcCtD
Alprazolam—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00417	CcSEcCtD
Alprazolam—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00401	CcSEcCtD
Alprazolam—Rash—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00398	CcSEcCtD
Alprazolam—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00397	CcSEcCtD
Alprazolam—Headache—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00395	CcSEcCtD
Alprazolam—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00375	CcSEcCtD
Alprazolam—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00255	0.0118	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0022	0.0102	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0022	0.0102	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00214	0.0099	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00214	0.0099	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0021	0.00972	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0021	0.00972	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00207	0.00956	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00207	0.00956	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00205	0.00949	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00205	0.00949	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00202	0.00932	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00202	0.00932	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00196	0.00908	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00191	0.00883	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00187	0.00867	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00184	0.00852	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00184	0.00852	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00183	0.00846	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0018	0.00831	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0018	0.00831	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0018	0.00831	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00176	0.00815	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00176	0.00815	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00175	0.00807	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00175	0.00807	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00171	0.00793	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00171	0.00793	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00168	0.00779	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00168	0.00779	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00167	0.00774	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00167	0.00774	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00164	0.0076	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00164	0.0076	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00157	0.00726	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00144	0.00664	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00144	0.00664	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00136	0.0063	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00136	0.0063	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00132	0.00612	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00132	0.00612	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0013	0.00601	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0013	0.00601	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.0013	0.00601	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00128	0.0059	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00128	0.0059	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00127	0.00586	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00127	0.00586	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00127	0.00585	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00127	0.00585	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00125	0.00576	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00125	0.00576	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00123	0.00569	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00123	0.00569	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00121	0.00558	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00121	0.00558	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00119	0.00549	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00119	0.00549	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00118	0.00545	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00118	0.00545	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00116	0.00535	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00116	0.00535	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00113	0.00522	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00113	0.00522	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—SPP1—nephrolithiasis	0.0011	0.00509	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0011	0.00507	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0011	0.00507	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00109	0.00503	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00109	0.00503	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00108	0.00498	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00108	0.00498	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00106	0.00489	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00106	0.00489	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00105	0.00486	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00105	0.00486	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00103	0.00477	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00103	0.00477	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00101	0.00468	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00101	0.00468	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000902	0.00417	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000902	0.00417	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000902	0.00417	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000876	0.00405	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000861	0.00398	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000857	0.00396	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000846	0.00391	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00084	0.00388	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000825	0.00381	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000721	0.00333	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000575	0.00266	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000513	0.00237	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000436	0.00202	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000436	0.00202	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000416	0.00192	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000371	0.00171	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000315	0.00146	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000315	0.00146	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000311	0.00144	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000293	0.00136	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000281	0.0013	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000261	0.00121	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000225	0.00104	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000222	0.00103	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000222	0.00103	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000203	0.000939	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000193	0.000894	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000172	0.000797	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000158	0.000732	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000146	0.000677	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000146	0.000677	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000143	0.000662	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000104	0.000483	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CHRM3—nephrolithiasis	9.44e-05	0.000436	CbGpPWpGaD
